Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
J. Vale, E. Silva, V. Melo, C. Capelão, A. R. Oliveira, I. Gil, P. Ribeiro, A. Sanchez Serrano, F. Girão, A. Simões Torres (Viseu, Portugal). Resistant arterial hypertension and obstructive sleep apnea syndrome. Eur Respir J 2012; 40: Suppl. 56, 3872

Member's Comments

No comment yet.

Related content which might interest you: Arterial hypertension in patients with obstructive sleep apnoea and overlap syndrome Source: Annual Congress 2009 - Control of breathing and respiratory disorders during sleep Year: 2009 Prevalence of obstructive sleep apnea among patients with resistant arterial hypertension Source: Eur Respir J 2005; 26: Suppl. 49, 115s Year: 2005 Arterial hypertension in patients with obstructive sleep apnea syndrome in cluj napoca, Romania Source: Annual Congress 2009 - Cardiovascular complications in obstructive sleep apnoea Year: 2009 Pulmonary hypertension and obstructive sleep apnea syndrome -Marmara Universitypediatric sleep laboratory experience Source: Virtual Congress 2020 – Respiratory physiology and sleep: what is new? Year: 2020 Masked hypertension and obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2006; 28: Suppl. 50, 416s Year: 2006 Prevalence of metabolic syndrome from patient with obstructive sleep apnea and hypertension Source: International Congress 2019 – Current perspectives in sleep-disordered breathing Year: 2019 Prevalence of metabolic syndrome in patients with hypertension and obstructive sleep apnea Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea Year: 2009 Unrecognised systemic hypertension in patients with obstructive sleep apnoea Source: Eur Respir J 2006; 28: Suppl. 50, 643s Year: 2006 Nocturnal intermitent hypoxemia in patients with pulmonary hypertension and sleep apnea hypopnea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 657s Year: 2006 Pulmonary arterial hypertension (PAH) in patients with obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2002; 20: Suppl. 38, 562s Year: 2002 Unrecognised obstructive sleep apnoea is common in severe peripheral arterial disease Source: Eur Respir J 2013; 41: 616-620 Year: 2013 Hypertension and obstructive sleep apnoea Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases Year: 2006 Comorbidities of obstructive sleep apnoea syndrome Source: Annual Congress 2011 - Comorbid obstructive sleep apnoea (OSA) and OSA comorbidities Year: 2011 Impact of CPAP-therapy on cardiac structure and function in patients with obstructive sleep apnea syndrome and coprevalent arterial hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 817s Year: 2006 Unrecognised hypertension in patients screened for obstructive sleep apnoea Source: Eur Respir J 2005; 26: Suppl. 49, 40s Year: 2005 Day time pulmonary hypertension in patients with obstructive sleep apnea hypopnea syndrome Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous Year: 2008 Cardiac arrythmias in chronic obstructive pulmonary disease and obstructive sleep apnoea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 645s Year: 2006 Endothelial function in obstructive sleep apnea syndrome Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea Year: 2011 Vasoconstriction during the night in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 419s Year: 2006